This article was originally published in The Tan Sheet
"Potentially severe drug-dietary supplement interactions were infrequent and comparable in incidence to potentially serious drug-drug interactions" in a population of 458 veteran outpatients from VA centers in Pittsburgh and Los Angeles, according to a study published in the March 22 Archives of Internal Medicine. Of 89 potential drug-supplement interactions identified, 6% were classified as severe, say Catherine Peng, Veterans Affairs Pittsburgh Healthcare System, et al. Most of the potential interactions identified were with ginseng, garlic, ginkgo, and coenzyme Q-10. Authors note 43% of the patients were taking at least one supplement with Rx medications...
You may also be interested in...
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.